Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Kandel
Economic Impact of the End of the Market Exclusivity for Orphan Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
PHP46 Market Uptake of Orphan Drugs – A European Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Potential Impact of the Cancer Drugs Fund Reform on Orphan Cancers
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy49 - Budgetary Impact of Orphan Drugs in the Catalan Healthcare Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Examining the Target Population of Orphan Drugs: Are Drugs Exceeding the Intended Purposes of the Orphan Drug Act?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Economic Impact of Herd Behavior in the Japanese Loan Market
Pacific Basin Finance Journal
Economics
Econometrics
Finance
Php325 - Orphan Drugs‘ Market Access Challenges in Europe From a German Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Impact of Stock Market Development on Economic Growth: The Case of Botswana
International Journal of Economics and Finance
